Search Results - "Barker, Colin M."

Association of Immature Platelets With Adverse Cardiovascular Outcomes by Ibrahim, Homam, MD, Schutt, Robert C., MD, Hannawi, Bashar, MD, DeLao, Timothy, MLT, Barker, Colin M., MD, Kleiman, Neal S., MD

“…Abstract Background Immature platelets are less responsive to the effects of antiplatelet drugs and contain messenger ribonucleic acid that is translationally…”
Get full text

Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center by Kalra, Ankur, MD, Rehman, Hasan, MD, Ramchandani, Mahesh, MD, Barker, Colin M., MD, Lawrie, Gerald M., MD, Reul, Ross M., MD, Reardon, Michael J., MD, Kleiman, Neal S., MD

“…Abstract Background The Trifecta valve (St Jude Medical, Inc, St Paul, Minn) was approved for commercial use by the US Food and Drug Administration in 2011…”
Get full text

Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention by Price, Matthew J., MD, Nayak, Keshav R., MD, Barker, Colin M., MD, Kandzari, David E., MD, Teirstein, Paul S., MD

“…Small studies have indicated that drug-drug interactions and such clinical characteristics as diabetes mellitus may increase residual platelet reactivity in…”
Get full text

Pre- and Post-Operative Diastolic Dysfunction in Patients With Valvular Heart Disease by Zaid, Rasheed R., MD, Barker, Colin M., MD, Little, Stephen H., MD, Nagueh, Sherif F., MD

“…Patients with valvular heart disease often have left ventricular diastolic dysfunction. This review summarizes the underlying mechanisms for diastolic…”
Get full text

Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality by Lindman, Brian R, Goel, Kashish, Bermejo, Javier, Beckman, Joshua, O'Leary, Jared, Barker, Colin M, Kaiser, Clayton, Cavalcante, João L, Elmariah, Sammy, Huang, Jian, Hickey, Graeme L, Adams, David H, Popma, Jeffrey J, Reardon, Michael J

“…Background Blood pressure (BP) guidelines for patients with aortic stenosis or a history of aortic stenosis treated with aortic valve replacement (AVR) match…”
Get full text

Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement by Goel, Kashish, O'Leary, Jared M, Barker, Colin M, Levack, Melissa, Rajagopal, Vivek, Makkar, Raj R, Bajwa, Tanvir, Kleiman, Neal, Linke, Axel, Kereiakes, Dean J, Waksman, Ron, Allocco, Dominic J, Rizik, David G, Reardon, Michael J, Lindman, Brian R

“…Background Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement…”
Get full text

The CoreValve US Pivotal Trial by Barker, Colin M., MD, Reardon, Michael J., MD

“…Transcatheter aortic valve replacement (TAVR) has been developed as a less-invasive approach to address patients at high risk to extreme risk for surgical…”
Get full text

Permanent Pacemaker Implantation After TAVR for Degenerated Bioprosthetic Surgical Valves: We Could Do Better by Barker, Colin M.

“…[Display omitted]…”
Get full text

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation by Johannesen, Sigrid L, Barker, Colin M, Levack, Melissa M

“…Ischaemic mitral regurgitation is a complex process with debate in the literature as to the optimal treatment pathway. Multiple therapies are available to…”
Get full text

Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Outcomes in Left Ventricular Assist Device Patients with Aortic Insufficiency by Rali, Aniket S, Taduru, Siva S, Tran, Lena E, Ranka, Sagar, Schlendorf, Kelly H, Barker, Colin M, Shah, Ashish S, Lindenfeld, JoAnn, Zalawadiya, Sandip K

“…Worsening aortic insufficiency (AI) is a known sequela of prolonged continuous-flow left ventricular assist device (LVAD) support with a significant impact on…”
Get full text

Outcome After Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease by Lee, Michael S., MD, Tseng, Chi-Hong, PhD, Barker, Colin M., MD, Menon, Venu, MD, Steckman, David, MD, Shemin, Richard, MD, Hochman, Judith S., MD

“…Background The ideal revascularization strategy (bypass surgery versus percutaneous coronary intervention [PCI]) for patients with cardiogenic shock in the…”
Get full text

Feasibility of a No-Implant Approach to Interatrial Shunts: Preclinical and Early Clinical Studies by Barker, Colin M., Meduri, Christopher U., Fail, Peter S., Chambers, Jeffrey W., Solet, Darrell J., Kriegel, Jacob M., Vela, Deborah C., Feldt, Kari, Pate, Thomas D., Patel, Avni P., Shaburishvili, Tamaz

“…Heart failure with preserved ejection fraction represents a major unmet clinical need with limited treatment options. Recent device therapies under…”
Get full text

Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patients by Cork, David P., McCullough, Peter A., Mehta, Hirsch S., Barker, Colin M., Gunnarsson, Candace, Ryan, Michael P., Baker, Erin R., Van Houten, Joanna, Mollenkopf, Sarah, Verta, Patrick

“…Aims Heart failure (HF) carries a poor prognosis, and the impact of concomitant mitral regurgitation (MR) is not well understood. This analysis aimed to…”
Get full text

Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity by Barker, Colin M., MD, Murray, Sarah S., PhD, Teirstein, Paul S., MD, Kandzari, David E., MD, Topol, Eric J., MD, Price, Matthew J., MD

“…Objectives The objective of this study was to evaluate the antiplatelet effect of clopidogrel 150 mg/day in patients with high on-treatment reactivity (OTR)…”
Get full text

Minimally Invasive Repair of Left Ventricular Pseudoaneurysm after Transapical Transcatheter Aortic Valve Replacement by Ramlawi, Basel, Abu Saleh, Walid K, Al Jabbari, Odeaa, Barker, Colin M, Kleiman, Neal S, Reardon, Michael J

“…Transcatheter aortic valve replacement is becoming a routine procedure to treat severe symptomatic aortic stenosis. At most transcatheter aortic valve…”
Get full text

3D Printed Modeling for Patient-Specific Mitral Valve Intervention: Repair With a Clip and a Plug by Little, Stephen H, Vukicevic, Marija, Avenatti, Eleonora, Ramchandani, Mahesh, Barker, Colin M

Get full text

Diagnostic Value of 3-Dimensional Vena Contracta Area for the Quantification of Residual Mitral Regurgitation After MitraClip Procedure by Avenatti, Eleonora, Mackensen, G. Burkhard, El-Tallawi, Kinan Carlos, Reisman, Mark, Gruye, Lara, Barker, Colin M., Little, Stephen H.

“…The authors sought to define the feasibility and performance of 3-dimensional (3D) vena contracta area (VCA) measurement in evaluating total residual mitral…”
Get full text

When to Choose Surgery in the Era of Transcatheter Aortic Valve Replacement by Wyler von Ballmoos, Moritz C., MD, PhD, MPH, Barker, Colin M., MD, Reardon, Michael J., MD

“…Treatment of severe symptomatic aortic stenosis has undergone significant changes with the advent of transcatheter aortic valve replacement (TAVR). Initially…”
Get full text

Transcatheter Tricuspid Interventions: Past, Present, and Future by Barker, Colin M, Goel, Kashish

“…Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume…”
Get full text

Bicuspid Aortic Valve Stenosis: Is There a Role for TAVR? by Barker, Colin M, Reardon, Michael J

“…Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis. A series of trials in which patients were randomized to…”
Get full text